Business Wire

Final Results From PATHFINDER Study of GRAIL’s Multi-Cancer Early Detection Blood Test Published in The Lancet

MENLO PARK, Calif.--(BUSINESS WIRE)--GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, today announced that detailed findings from the PATHFINDER study of ...
Seeking Alpha

Patient Reported Outcomes for GRAIL's Galleri® Multi-Cancer Early Detection Blood Test Published in Lancet Oncology

Analysis of Patient Reported Outcomes From PATHFINDER Indicate Minimal Patient Distress Associated with Multi-Cancer Early Detection Testing MENLO PARK, Calif., Jan. 13, 2025 /PRNewswire/ -- GRAIL, ...
Hosted on MSN

HbA1c test may be inaccurate for millions of Indians: Lancet study

The widely used glycated haemoglobin (HbA1c) test may not accurately reflect blood glucose levels for millions of Indians, according to a new evidence-based viewpoint published online in the Lancet ...
Pharmabiz

Lancet study reveals standard diabetes test may mislead diagnosis and monitoring in South Asian populations

A new evidence-based viewpoint published online in Lancet Regional Health: Southeast Asia highlights that the widely used glycated haemoglobin (HbA1c) test, as available in India, may not accurately ...